How government-dependent is INTERCEPT PHARMACEUTICALS INC?

In fiscal year 2022, US federal obligations equal 0.0% of INTERCEPT PHARMACEUTICALS INC's reported revenue - $0 in federal awards against $285.7M in revenue as filed with the SEC. In fiscal year 2021 the share was 0.0%.

Cite as: FACTANKER, https://factanker.com/entity/2f36cbce-f2d5-4031-ac23-0ad45513c69f/government-dependency

Fiscal year	Revenue (SEC, as filed)	Federal obligations	Share	Data status
FY 2022	$285.7M	$0	0.0%	complete
FY 2021	$260.8M	$0	0.0%	none

Evidence
Revenue FY 2022: evidence fact fe2d8f82… (SEC filing)
Federal obligations FY 2022: sum of 3 award records (USAspending bulk data)
Identity consolidation: CIK 0001270073 · LEI 254900JMB8TX5P688V24 · UEI GHNKCLBJRMK7 - linked via evidence-backed same_as facts, see all facts of this organization

Methodology & sources
Revenue: company fiscal year, as filed with the SEC (XBRL concept per evidence fact). Obligations: US federal fiscal year of the award date, consolidated across all registrations of the corporate group. Computed in the database, precomputed weekly - never by a model. Sources: SEC EDGAR, USAspending (public domain).

Not claimed

The two periods do not align exactly: revenue follows the company's fiscal year, obligations the US federal fiscal year (Oct-Sep).
Years marked 'contracts only': grant/assistance awards are not yet loaded - the share is a floor, not the full figure.
Fiscal years without a share: obligations base files not yet loaded; a missing value means missing load, not zero government business.
Obligations are amounts obligated, not amounts paid out.
The share consolidates all registrations of the corporate group via evidence-backed identity links (same_as facts).

INTERCEPT PHARMACEUTICALS INC - all facts · Use this metric in your own models: JSON/API · API/MCP quickstart